The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...

The Leela is entering a new phase of expansion post its IPO, but it is not straying away from its luxury proposition.

An analysis reveals a spike in pro-Russian disinformation networks surrounding the attempt to oust the European Commission ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private sector, but not yet in public clinics. The country’s advisory group on ...

These updates support Ocugen in its efforts to pursue its goal of 3 biologics license applications (BLA) in the next 3 years.

Dividned stocks: 15 small-cap stocks have given dividends of up to ₹200 in the last 12 months, resulting in a dividend yield ...

AstraZeneca, Pfizer and other multinational drug companies have spent a record amount on medicines developed by Chinese biotechs this year, underscoring how Big Pharma is increasingly reliant on China ...

The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...